Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 181 - 190 of 1441 shown below

  • Garbay, J R

    L Mauriac, E Luporsi, B Cutuli, A Fourquet, J R Garbay, S Giard, F Spyratos, B Sigal-Zafrani, J M Dilhuydy, V Acharian, C Balu-Maestro, M P Blanc-Vincent, C Cohen-Solal, B De Lafontan, M H Dilhuydy, B Duquesne, R Gilles, A Lesur, N Shen, L Cany, I Dagousset, M H Gaspard, H Hoarau, A Hubert, M H Monira, N Perrié and G Romieu

    Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

    doi:10.1038/sj.bjc.6601081

  • S Négrier, B Fervers, C Bailly, V Beckendorf, D Cupissol, J F Doré, T Dorval, J R Garbay and C Vilmer

    Cutaneous melanoma

    doi:10.1054/bjoc.2001.1771

  • Garbe, C

    P Radny, U M Caroli, J Bauer, T Paul, C Schlegel, T K Eigentler, B Weide, M Schwarz and C Garbe

    Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

    doi:10.1038/sj.bjc.6601320

  • J Bauer, E Kilic, J Vaarwater, B C Bastian, C Garbe and A de Klein

    Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma

    advance online publication, 2009-08-04 00:00:00.000;

    doi:10.1038/sj.bjc.6605226

  • R Hipfel, B Schittek, Y Bodingbauer and C Garbe

    Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization

    doi:10.1054/bjoc.1999.1055

  • A Hauschild, C Garbe, W Stolz, U Ellwanger, S Seiter, R Dummer, S Ugurel, G Sebastian, D Nashan, R Linse, W Achtelik, P Mohr, R Kaufmann, M Fey, J Ulrich and W Tilgen

    Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)

    doi:10.1054/bjoc.2001.1731

  • Garbett, E A

    E A Garbett, M W R Reed and N J Brown

    Proteolysis in human breast and colorectal cancer

    doi:10.1038/sj.bjc.6690689

  • Garbi, A

    R Fruscio, N Colombo, A A Lissoni, A Garbi, R Fossati, N Ieda', V Torri and C Mangioni

    A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis

    advance online publication, 2008-02-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604231

  • Garbisa, S

    A Vacca, M Bruno, A Boccarelli, M Coluccia, D Ribatti, A Bergamo, S Garbisa, L Sartor and G Sava

    Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A

    doi:10.1038/sj.bjc.6600176

  • Garbrecht-Buettner, S

    K-U Petry, S Menton, M Menton, F van Loenen-Frosch, H de Carvalho Gomes, B Holz, B Schopp, S Garbrecht-Buettner, P Davies, G Boehmer, E van den Akker and T Iftner

    Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

    doi:10.1038/sj.bjc.6600918

  • García, Á M

    H Boulaiz, J Prados, C Melguizo, Á M García, J A Marchal, J L Ramos, E Carrillo, C Vélez and A Aranega

    Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene

    doi:10.1038/sj.bjc.6601064

  • García, EB Gómez

    A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernström, M S Askmalm, B Arver, B Malmer, S M Domchek, K L Nathanson, J Brunet, T Ramón y Cajal, D Yannoukakos, U Hamann, F B L Hogervorst, S Verhoef, EB Gómez García, J T Wijnen, A van den Ouweland, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Révillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Deis zligler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice and J Benítez

    Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605416

  • García Rodríguez, L A

    L A García Rodríguez and A González-Pérez

    Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

    advance online publication, 2004-06-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602003

  • M Lindblad, L A García Rodríguez, E Chandanos and J Lagergren

    Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas

    advance online publication, 2005-12-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602906

  • García del Muro, J

    A López-Pousa, R Losa, J Martín, J Maurel, J Fra, M Sierra, A Casado, J García del Muro, A Poveda, C Balañá, J Martínez-Trufero, E Esteban and J M Buesa

    Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

    advance online publication, 2006-05-23 00:00:00.000;

    doi:10.1038/sj.bjc.6603187